BioSpace News Archive

Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, which are jointly developing urokinase plasminogen activator receptor targeted radio-immuno-therapeutics (uPRITs) for the potential treatment of patients with severe COVID-19, today announced a collaboration with The University of Texas Health Science Center at Tyler (UTHSCT) and its Texas Lung Injury Institute (TLII)

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference at 3:30 p.m. ET on Tuesday, September 15, 2020. Company management will also participate in one-on-one mee

Avricore Health Inc.(TSXV: AVCR, OTC: AVCRF) (“Avricore” or the “Company”) a leader in pharmacy-based point-of-care testing solutions, plans to offer its HealthTab™ system as a stand-alone service to improve COVID19 case reporting.

Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that its licensing partner, REGENXBIO Inc. (Nasdaq: RGNX), has dosed the first patient in its Phase 2 clinical trial to evaluate the suprachoroidal delivery of RGX-314, an adeno-associated virus (AAV) gene therapy, using Clear

A new in vitro study just published in the Journal of Gastroenterology Research by Howard F. Robins and A. Reza Kamarei has shown complete inhibition of Clostridium difficile (C. diff) , a life-threatening diarrhea causing bacteria, by a patent-pending synbiotic product (blend of 15 strains of living probiotics in a blend of organic vegetable-fruit juice)

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the limited availability of the new Precice® Plate for use in limb lengthening and reconstruction procedures from NuVasive Specialized Orthopedics

Oncomfort, the Belgian inventor of and leader in Digital SedationTM - a method for relieving patients’ pain and anxiety without medication - today announces the completion of a €10 million Series A funding round co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation.

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that Dr. Martin Madaus will be joining as the company’s Chief Operations Officer to assist in the rapid expansion of Sherlock in the next 12 months. Dr. Madaus brings to Sherl

Experion Holdings Ltd.announced today that CEO, Mr. Jarrett Malnarich will present live at VirtualInvestorConferences.com on September 10 at 4:00 PM EDT / 1:00 PM PDT.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support for the Scoliosis Research Society, including the Company’s Gold Level sponsorship for the 55th Annual Meeting & Course taking place virtually on September 9-13.